Encompass Health

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984, and is headquartered in Birmingham, AL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Encompass Health reports robust Q4 performance amidst operational challenges

Encompass Health delivered a strong performance in Q4 2022, showcasing financial growth, effective cost management, and strategic investments in hospital expansions.
While facing challenges such as administrative delays in de novo hospitals and fluctuations in case mix, the company remains focused on leveraging opportunities in market density and regulatory engagement.
With a clear focus on financial stability, growth opportunities, and strategic planning, Encompass Health aims to navigate industry challenges and drive future success.

Encompass Health reports strong Q1 earnings, eyes growth opportunities

Encompass Health (EHC) delivered a robust performance in Q1 2023, showcasing financial growth and operational efficiency.
While facing challenges in labor expenses and capacity constraints, the company remains focused on growth strategies and maintaining strong financial performance.
With raised guidance for 2023 and investments in technology, Encompass Health is poised to capitalize on opportunities for market expansion and improved patient outcomes.

Encompass Health reports robust Q2 earnings, eyes Medicare Advantage growth

Encompass Health's Q2 performance showcased strong revenue and EBITDA growth, driven by volume increases and cost efficiencies. The company's focus on strategic investments, capacity expansions, and optimizing Medicare Advantage revenues positions it well for future growth. Challenges in managing occupancy rates and potential Medicare payment structure changes require careful monitoring.

Encompass Health reports robust Q3 results amid labor cost reductions

Encompass Health's Q3 performance showcased strong revenue growth, operational efficiency, and effective cost management strategies.
The company's focus on key patient categories and capacity expansions position it well for future growth and market relevance.
While challenges like labor market dynamics persist, Encompass Health's strategic initiatives and financial outlook remain positive.

Encompass Health reports robust Q4 performance amidst growth investments

Encompass Health's Q4 2023 performance reflects strong financial growth, operational efficiency, and strategic investments, positioning the company for continued success.
While challenges such as labor inflation and margin sustainability persist, the company's focus on clinical innovation and readiness for regulatory changes bode well for future growth.
Opportunities in managed care, value-based arrangements, and expansion plans offer Encompass Health avenues for further development and enhancing its value proposition in the healthcare sector.

Encompass Health excels in Q1, poised for strategic growth

Encompass Health's Q1 performance reflects robust growth, operational resilience, and strategic foresight amidst industry challenges.
The company's focus on clinical excellence, capacity expansion, and financial discipline positions it for sustained success and market leadership.
While facing cybersecurity risks and regulatory uncertainties, Encompass Health's proactive approach and strong fundamentals mitigate potential challenges.
Encompass Health's upwardly revised guidance, strong patient volume trends, and investment in technology underscore its commitment to growth and innovation.

Encompass Health excels in Q3 2024, poised for growth

Encompass Health's Q3 2024 performance reflects robust revenue growth, operational efficiency, and strategic investments in capacity expansion.
The company's financial strength, resilience to operational challenges, and focus on innovation position it well for future growth opportunities.
While facing potential challenges in a dynamic healthcare landscape, Encompass Health has opportunities to drive growth through strategic initiatives and market expansion.
Overall, Encompass Health's strong performance, prudent financial management, and growth outlook make it a compelling player in the healthcare industry.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.

BIRMINGHAM, Ala. , April 27, 2022 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, today reported its results of operations for the first quarter ended March 31, 2022.

Encompass Health reports results for first quarter 2022

BIRMINGHAM, Ala. , April 25, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the BofA Securities 2022 Healthcare Conference being held in Las Vegas May 10-12 and virtually on May 13, 2022.

Encompass Health to present at BofA Securities 2022 Healthcare Conference

Encompass Health (EHC) commences operations in its North Alabama hospital, which has been relocated with added capacity for better serving residents of the Huntsville community.

Encompass Health (EHC) Relocates North Alabama Hospital

HUNTSVILLE, Ala. , April 11, 2022 /PRNewswire/ -- Encompass Health (NYSE: EHC) announces the opening of a new location for Encompass Health Rehabilitation Hospital of North Alabama , an 85-bed inpatient rehabilitation hospital.

Encompass Health Rehabilitation Hospital of North Alabama opens new location in Huntsville with 85 private patient rooms

Announces retirement of five directors BIRMINGHAM, Ala. , March 31, 2022 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced the appointment of Kevin J.

Encompass Health appoints Kevin O'Connor to its Board of Directors

BIRMINGHAM, Ala., March 25, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its first quarter ended March 31, 2022, after the market closes on April 27, 2022.

Encompass Health announces date of 2022 first quarter earnings call

Encompass Health (EHC) opens a 60-bed inpatient rehabilitation hospital in Illinois, sustaining its aim to offer enhanced rehabilitation services throughout the United States.

Encompass Health's (EHC) Nationwide Hospital Count Rises to 147

Encompass Health Rehabilitation Institute of Libertyville, a 60-bed inpatient rehabilitation hospital, now open

Encompass Health (EHC) increases its nationwide inpatient rehabilitation hospital count to 147 with the recently inaugurated 40-bed hospital in St. Augustine, FL.

Encompass Health (EHC) Inaugurates New Hospital in Florida

BIRMINGHAM, Ala., and ST. AUGUSTINE, Fla.

Encompass Health Rehabilitation Hospital of St. Augustine now open

Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock?

Why Is Encompass Health (EHC) Up 6.5% Since Last Earnings Report?

BIRMINGHAM, Ala., Feb. 28, 2022 /PRNewswire/ -- Encompass Health Corporation ("Encompass Health" or the "Company") (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, in response to recent discussions with stockholders, including JANA Partners LLC, today provided the following updates with respect to its previously disclosed Board refreshment process and planned separation of the Company's home health and hospice business, Enhabit.

Encompass Health Corporation provides updates regarding Board refreshment, separation of home health and hospice business

Encompass Health (EHC) joins forces with Lee Health in a bid to construct two inpatient rehabilitation hospitals in Southwest Florida and deliver better health outcomes across the region.

Encompass Health (EHC) Ties Up to Better Serve Florida Residents

Encompass Health and Lee Healthcare Holdings, LLC announce a collaboration to jointly own and operate two inpatient rehabilitation hospitals in Florida

BIRMINGHAM, Ala., Feb. 21, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it has been named to Fortune's 'World's Most Admired Companies' for 2022.

Encompass Health Corp. Named One of the World's Most Admired Companies in 2022 by Fortune

The Rehabilitation Institute of Southern Illinois, a 40-bed inpatient rehabilitation hospital, now open in Shiloh

BIRMINGHAM, Ala., Feb. 11, 2022 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today issued notice for redemption of the remaining $100 million of the outstanding principal balance of its 5.125% senior notes due 2023 (the "2023 Notes").

Encompass Health issues notice for final redemption of its 5.125% senior notes due 2023

BIRMINGHAM, Ala., Feb. 4, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the SVB Leerink 11th Annual Virtual Global Healthcare Conference taking place February 14-18, 2022.

Encompass Health to participate in the SVB Leerink 11th Annual Virtual Global Healthcare Conference

Encompass Health's (EHC) Q4 results reflect escalating costs, partly offset by higher revenues, courtesy of its Inpatient Rehabilitation segment.

Encompass Health's (EHC) Q4 Earnings Miss Mark, Increase Y/Y

Encompass Health Corporation (EHC) CEO Mark Tarr on Q4 2021 Results - Earnings Call Transcript

Encompass Health Corporation EHC posted Q4 sales of $1.32 billion, +8.6% Y/Y, in line with the consensus of $1.32. Thousands of new traders are learning the ins and outs on how to find profitable trades every day with Benzinga Trading School.

Why Are Encompass Health Shares Tanking Today Premarket?

Encompass Health (EHC) delivered earnings and revenue surprises of -8.49% and 1.09%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Encompass Health (EHC) Q4 Earnings Lag Estimates

BIRMINGHAM, Ala., Feb. 1, 2022 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, today reported its results of operations for the fourth quarter and full year ended December 31, 2021.

Encompass Health reports results for fourth quarter 2021 and issues full-year 2022 guidance

BIRMINGHAM, Ala. and MIAMI , Feb. 1, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), a national leader in integrated post-acute healthcare services, and Baptist Health South Florida are pleased to announce an expanded joint venture agreement to include the Baptist Health home health agency in Miami, Florida.

Encompass Health and Baptist Health South Florida expand home health joint venture in Miami, Florida

BIRMINGHAM, Ala., Jan. 25, 2022 /PRNewswire/ -- Encompass Health Corporation ("Encompass Health" or the "Company") (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, today announced that it has received the required consents (the "Required Consents") from holders of its 4.500% Senior Notes due 2028 (the "2028 Notes"), 4.750% Senior Notes due 2030 (the "2030 Notes") and 4.625% Senior Notes due 2031 (the "2031 Notes" and together with the 2028 Notes and 2030 Notes, the "Notes") to certain proposed amendments (the "Proposed Amendments") described in the Consent Solicitation Statement, dated December 9, 2021 (as amended on December 16, 2021, January 12, 2022, January 18, 2022 and January 20, 2022, the "Statement") to the indenture governing the Notes (the "Indenture").

Encompass Health Corporation Announces Execution of Supplemental Indenture for its 4.500% Senior Notes due 2028, 4.750% Senior Notes due 2030 and 4.625% Senior Notes due 2031

News for Encompass Health Stock (EHC)